Poolbeg Pharma Plc

(LSE) POLB

Current Price£0.08

Market Cap£55.56M

Since IPO (2021)-27%

5 YearN/A

1 Year+132%

1 Month+59%

Poolbeg Pharma Plc Financials at a Glance

Market Cap

£55.56M

Revenue (TTM)

£0.00

Net Income (TTM)

-£11.49M

EPS (TTM)

-£0.01

P/E Ratio

-8.47

Dividend

£0.00

Beta (Volatility)

-0.04 (Low)

Dividend

£0.00

Beta (Volatility)

-0.04 (Low)

Price

£0.08

Volume

1,338,021

Open

£0.08

Price

£0.08

Volume

1,338,021

Open

£0.08

Previous Close

£0.08

Daily Range

£0.07 - £0.08

52-Week Range

£0.03 - £0.09

Estimated Earnings Date

Sep 8, 2026

Dividend

£0.00

Beta (Volatility)

-0.04 (Low)

Price

£0.08

Volume

1,338,021

Open

£0.08

Previous Close

£0.08

Daily Range

£0.07 - £0.08

52-Week Range

£0.03 - £0.09

Estimated Earnings Date

Sep 8, 2026

POLB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Poolbeg Pharma Plc

Industry

Pharmaceuticals

Sector

Health Care

CEO

Jeremy Skillington, PhD

Website

www.poolbegpharma.com

Headquarters

London, E1 2AX, GB

POLB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-64%

Return on Capital

-75%

Return on Assets

-57%

Earnings Yield

-11.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£55.56M

Shares Outstanding

705.10M

Volume

1.34M

Avg. Volume

1.89M

Financials (TTM)

Gross Profit

-£59.00K

Operating Income

-£6.42M

EBITDA

-£6.36M

Operating Cash Flow

-£4.51M

Capital Expenditure

£4.51M

Free Cash Flow

-£4.84M

Cash & ST Invst.

£7.71M

Total Debt

£0.00

Poolbeg Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

£0.00

N/A

Gross Profit

-£33.00K

-153.8%

Gross Margin

0.00%

N/A

Market Cap

£55.56M

N/A

Market Cap/Employee

£3.70M

N/A

Employees

N/A

Net Income

-£3.52M

-65.9%

EBITDA

-£3.83M

-42.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

£7.71M

-36.6%

Total Debt

£0.00

N/A

Accounts Receivable

£555.00K

-20.7%

Inventory

£0.00

N/A

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-57.28%

N/A

Return on Invested Capital

-74.62%

N/A

Free Cash Flow

-£2.16M

-10.9%

Operating Cash Flow

-£2.16M

-17.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc£7.78+4.36%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc£0.22-4.35%

NCYT.LNovacyt S.A.

NCYT.LNovacyt S.A.£0.35+1.72%

FAB.LFusion Antibodies plc

FAB.LFusion Antibodies plc£0.12-2.08%

IXI.LIXICO plc

IXI.LIXICO plc£0.09-1.14%

RENX.LRenalytix Plc

RENX.LRenalytix Plc£0.02+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

NOKNokia

NOKNokia$13.83-0.01%

NUNu Holdings

NUNu Holdings$12.89+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

HOODRobinhood Markets

HOODRobinhood Markets$105.20+0.09%

Questions About POLB

What is the current price of Poolbeg Pharma Plc?

Poolbeg Pharma Plc is trading at £0.08 per share.

What is the 52-week range for Poolbeg Pharma Plc?

Over the past 52 weeks, Poolbeg Pharma Plc has traded between £0.03 and £0.09.

How much debt does Poolbeg Pharma Plc have?

As of the most recent reporting period, Poolbeg Pharma Plc reported total debt of £0.00.

How much cash does Poolbeg Pharma Plc have on hand?

Poolbeg Pharma Plc reported £7.71M in cash and cash equivalents in its most recent financial results.

What is Poolbeg Pharma Plc’s dividend yield?

Poolbeg Pharma Plc does not currently have a dividend yield.

Poolbeg Pharma Plc

Poolbeg Pharma Plc Financials at a Glance

POLB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Poolbeg Pharma Plc

POLB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Poolbeg Pharma Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About POLB

What is the current price of Poolbeg Pharma Plc?

What is the 52-week range for Poolbeg Pharma Plc?

How much debt does Poolbeg Pharma Plc have?

How much cash does Poolbeg Pharma Plc have on hand?

What is Poolbeg Pharma Plc’s dividend yield?

Premium Investing Services